Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)
Catalog No.
F1480
Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)
Featured Products
Tavolixizumab (MEDI 0562; Tavolimab) is a humanized TNFRSF4 (TNF receptor superfamily member 4) monoclonal antibody for cancer immunology research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.36 kDa
Dry ice
1635395-25-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MEDI0562, MEDI-0562, tavolimab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P43489
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD134 His at 2 ug/mL can bind Anti-TNFRSF4/OX40/CD134 Antibody (Tavolixizumab)
TNFRSF4 / OX40 / CD134
Please avoid freeze-thaw cycles.